doi:10.3969/j.issn.1673-8640.2017.012.023

Abstract

CLC Number:

R446.62

Figures/Tables 2

References 12

[1]	Centers for Diseases Control and Prevention(CDC). Progress in hepatitis B prevention through universal infant vaccination-China,1997-2006[J].MMWR Morb Mortal Wkly Rep,2007,56(18):441-445.
[2]	戴志澄,祁国明. 中国病毒性肝炎血清流行病学调查[M]. 北京:科技技术文献出版社,1997:39-59.
[3]	ZHAO S M,LI H C,LOU H,et al.High prevalence of HBV in Tibet,China[J]. Asian Pac J Cancer Prev,2001,2(4):299-304.
[4]	LIU J,ZHANG S,WANG Q,et al.Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China:a population-based,cross-sectional study[J]. Lancet Infect Dis,2016,16(1):80-86.
[5]	ZHANG Y,FANG W,FAN L,et al.Hepatitis B surface antigen prevalence among 12 393 rural women of childbearing age in Hainan Province,China:a cross-sectional study[J].Virol J,2013,10:25.
[6]	LUO Z,XIE Y,DENG M,et al.Prevalence of hepatitis B in the southeast of China:a population-based study with a large sample size[J]. Eur J Gastroenterol Hepatol,2011,23(8):695-700.
[7]	LU FM,LI T,LIU S,et al.Epidemiology and prevention of hepatitis B virus infection in China[J]. J Viral Hepat,2010,17(Suppl 1):4-9.
[8]	中华人民共和国卫生部. 2006~2010年全国乙型病毒性肝炎防治规划[EB/OL]. (2006-01-28)[2016-10-08]. .
[9]	GHEORGHE L,CSIKI I E,IACOB S,et al.The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania:a nationwide survey[J]. Eur J Gastroenterol Hepatol,2013,25(1):56-64.
[10]	LIAO X Y,ZHOU Z Z,WEI F B,et al.Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization[J]. Hum Vaccin Immunother,2014,10(1):224-231.
[11]	中华人民共和国卫生部. 2004年全国计划免疫审评报告[M]. 北京:人民卫生出版社,2005:10-57.
[12]	中华人民共和国卫生部疾控司,中国疾病预防控制中心. 2006年全国人群乙肝血清流行病学调查结果[M]. 北京:人民卫生出版社,2011:30-46.

年龄组别（岁）	例数	HBsAg		HBcAb		HBsAb		单独HBsAb
年龄组别（岁）	例数	阳性	阳性率（%）	阳性	阳性率（%）	阳性	阳性率（%）	阳性	阳性率（%）
2~3	37	1	2.7	1	2.7	6	16.2	6	16.2
4~5	37	1	2.7	1	2.7	12	32.4	12	32.4
6~7	29	0	0.0	0	0.0	9	31.0	9	31.0
8~9	31	1	3.2	2	6.5	11	35.5	10	32.3
10~11	34	2	5.9	4	11.8	13	38.2	11	32.4
12~13	37	3	8.1	4	10.8	13	35.1	12	32.4
14~15	31	2	6.5	3	9.7	11	35.5	10	32.3
16~17	33	3	9.1	3	9.1	9	27.3	9	27.3
18~19	29	2	6.9	2	6.9	8	27.6	8	27.6
合计	298	15	5.0	20	6.7	92	30.9	87	29.2

年龄组别（岁）	例数	HBsAg		HBcAb		HBsAb		单独HBsAb
年龄组别（岁）	例数	阳性	阳性率（%）	阳性	阳性率（%）	阳性	阳性率（%）	阳性	阳性率（%）
2~3	37	1	2.7	1	2.7	6	16.2	6	16.2
4~5	37	1	2.7	1	2.7	12	32.4	12	32.4
6~7	29	0	0.0	0	0.0	9	31.0	9	31.0
8~9	31	1	3.2	2	6.5	11	35.5	10	32.3
10~11	34	2	5.9	4	11.8	13	38.2	11	32.4
12~13	37	3	8.1	4	10.8	13	35.1	12	32.4
14~15	31	2	6.5	3	9.7	11	35.5	10	32.3
16~17	33	3	9.1	3	9.1	9	27.3	9	27.3
18~19	29	2	6.9	2	6.9	8	27.6	8	27.6
合计	298	15	5.0	20	6.7	92	30.9	87	29.2

组别	例数	HBsAg 阳性	HBsAg阳性率（%）	P 值
低年龄组乙型肝炎疫苗接种				<0.001
是	140	1	0.7
否	9	2	22.2
高年龄组乙型肝炎疫苗接种				<0.001
是	104	3	2.9
否	45	9	20.0

组别	例数	HBsAg 阳性	HBsAg阳性率（%）	P 值
低年龄组乙型肝炎疫苗接种				<0.001
是	140	1	0.7
否	9	2	22.2
高年龄组乙型肝炎疫苗接种				<0.001
是	104	3	2.9
否	45	9	20.0

[1]	TANG Qingqin, QIAO Longwei, YIN Jingping, ZHANG Sheng, FENG Bin, LIANG Yuting. Correlation of peripheral blood monocyte count and serum anti-phospholipase A2 receptor antibody in patients with nephrotic syndrome [J]. Laboratory Medicine, 2023, 38(7): 647-652.
[2]	WANG Haiping, LI He. BISAP score combined with serum sRAGE for predicting hyperlipidemic acute pancreatitis severity and short-term prognosis [J]. Laboratory Medicine, 2023, 38(7): 653-658.
[3]	WU Jie, LI Zenghe, CHEN Baorong, KONG Xujing. Establishment of traceable steroid hormone standard curve for dried blood spot samples [J]. Laboratory Medicine, 2023, 38(5): 489-493.
[4]	. [J]. Laboratory Medicine, 2023, 38(3): 291-293.
[5]	. [J]. Laboratory Medicine, 2023, 38(1): 100-102.
[6]	. [J]. Laboratory Medicine, 2022, 37(9): 892-893.
[7]	SUN Xiaodan, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GAO Feng, YANG Cuixia. Research progress on the role of estrogen receptor in osteosarcoma [J]. Laboratory Medicine, 2022, 37(4): 313-318.
[8]	SUN Xiaodan, XU Jing, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GAO Feng, YANG Cuixia. Inhibitory effects of antiestrogen on the proliferation and CCL2 expression of osteosarcoma cells [J]. Laboratory Medicine, 2022, 37(4): 319-324.
[9]	CHEN Si, LIU Hua, LIU Yiwen, HE Yiqing, ZHANG Guoliang, YANG Cuixia, DU Yan, GAO Feng. Clinical significance of combined determination of serum HER-2 and CD44 in colorectal cancer [J]. Laboratory Medicine, 2022, 37(4): 336-341.
[10]	ZHAO Mingna, ZHANG Chenzi, HONG Qiushuang, LOU Jiatao. Mechanism of IL-8/miR-182 positive feedback regulatory axis in non-small cell lung cancer [J]. Laboratory Medicine, 2022, 37(4): 349-355.
[11]	ZHANG Zhibin, YANG Wanyong, RUAN Fuwang, WEN Qinghui. Roles of total IgE,sIgE and 25（OH）D in the evaluation of infant atopic dermatitis [J]. Laboratory Medicine, 2022, 37(3): 217-220.
[12]	. [J]. Laboratory Medicine, 2021, 36(12): 1264-1266.
[13]	QIU Fang, ZHU Ping, JIANG Peng, WANG Chan. Relation between anti-gp210 antibody,anti-sp100 antibody and ALBI score in patients with primary biliary cholangitis [J]. Laboratory Medicine, 2021, 36(11): 1106-1109.
[14]	. [J]. Laboratory Medicine, 2021, 36(9): 925-928.
[15]	LIU Yang, ZHANG Zhiping, PENG Daorong, SONG Liuwei, GE Shengxiang, HAO Xiaoke, LIU Jiayun. Establishment and performance evaluation of chemiluminescent microparticle immunoassay for the determination of high concentration HbsAg [J]. Laboratory Medicine, 2020, 35(10): 1056-1061.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 12

Related Articles 15

Recommended Articles

Metrics